Eli Lilly, Gates Foundation to supply COVID-19 antibody drug to low-income countries

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.

Eli Lilly said it will make specific volumes of its antibody drug available to lower-income nations before April 2021 if it gets approval in time and will make the drug in other facilities..

More posts on drug store:6 medical facilities, health systems opening brand-new pharmaciesWalgreens pharmacies to offer expanded medical services in ChicagoRite Aid to get Seattle-based drug store chain for $95M.

” To assist end the COVID-19 pandemic it is essential that people, no matter where they live or their capability to pay, can access reliable therapies,” said Mark Suzman, CEO of the Gates Foundation. “It is encouraging to see Lilly stepping up and committing to making items more economical and available to everyone who needs them. © Copyright ASC COMMUNICATIONS 2020.

Maia Anderson –
Friday, October 9th, 2020
Print|Email.

” To assist end the COVID-19 pandemic it is important that people, no matter where they live or their capability to pay, can access effective therapies,” said Mark Suzman, CEO of the Gates Foundation. “It is encouraging to see Lilly stepping up and committing to making products more cost effective and available to everyone who requires them. Till every nation can successfully take on COVID-19, no nation will be safe.”.

Part of the Gates Foundations COVID-19 Therapeutics Accelerator, an initiative to speed the advancement of and access to therapies for COVID-19, Eli Lilly said it will begin business production of its antibody drug in April 2021, pending regulatory approval, at Fujifilm factory in Denmark..

The drugmaker stated the other business it dealt with to develop the drug have actually consented to waive their royalties..

Read the full press release here.

Eli Lilly and the Bill & & Melinda Gates Foundation will partner to supply the drugmakers COVID-19 antibody drug to low- and middle-income countries, Eli Lilly stated Oct. 8.